Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care

B C Delaney1, S Wilson, A Roalfe

  • 1Department of Primary Care and General Practice, Division of Primary Care, Public and Occupational Health, University of Birmingham Medical School, Birmingham B15 2TT, UK. b.c.delaney@bham.ac.uk

BMJ (Clinical Research Ed.)
|April 17, 2001
PubMed

Insights

Near patient testing for Helicobacter pylori (H pylori) and endoscopy increased procedure rates but not symptom relief or quality of life. This strategy proved more costly than standard care for dyspepsia management.

Area of Science:

  • Gastroenterology
  • Health Economics
  • Primary Care Medicine

Background:

  • Dyspepsia is a common condition managed in primary care.
  • Helicobacter pylori (H pylori) infection is a potential cause of dyspepsia.
  • Current management strategies vary, impacting resource utilization and patient outcomes.

Purpose of the Study:

  • To evaluate the cost-effectiveness of a near-patient H pylori testing strategy followed by endoscopy for dyspepsia management.
  • To compare this strategy against usual primary care practices.

Main Methods:

  • A randomized controlled trial involving 478 patients under 50 years old with dyspepsia was conducted across 31 UK primary care centers.
  • The intervention group received near-patient H pylori testing with open-access endoscopy for positive results.
  • The control group received standard care, including acid-suppressing drugs or specialist referral at the general practitioner's discretion.

Main Results:

  • The intervention group showed higher rates of H pylori testing (40%) and endoscopy (45% vs. 25% in controls).
  • Peptic ulcer diagnoses were more frequent in the intervention group (7.4% vs. 2.1%).
  • No significant differences were observed in symptom improvement, quality of life, prescribing, consultation, or referral rates between groups. The intervention group incurred higher costs (£367.85 vs. £253.16 per patient).

Conclusions:

  • The near-patient H pylori testing and endoscopy strategy effectively increases endoscopy utilization in primary care.
  • However, this strategy does not provide additional benefits in symptom relief or quality of life compared to usual care.
  • The increased costs associated with the intervention strategy are not offset by demonstrable clinical or quality-of-life improvements.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...